Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 773

1.

Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.

Petrovski G, Dimitrovski C, Bogoev M, Milenkovic T, Ahmeti I, Bitovska I.

Diabetes Technol Ther. 2011 Nov;13(11):1109-13. doi: 10.1089/dia.2011.0081.

PMID:
21751889
2.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
3.

Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.

Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M.

Diabetes Care. 2009 Dec;32(12):2245-50. doi: 10.2337/dc09-0750.

4.

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.

Clin Ther. 2008 Aug;30(8):1476-84. doi: 10.1016/j.clinthera.2008.08.013.

PMID:
18803989
5.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
7.

Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.

Wojciechowski P, Ryś P, Lipowska A, Gawęska M, Małecki MT.

Pol Arch Med Wewn. 2011 Oct;121(10):333-43. Review.

8.

Continuous glucose monitoring-enabled insulin-pump therapy in diabetic pregnancy.

Secher AL, Schmidt S, Nørgaard K, Mathiesen ER.

Acta Obstet Gynecol Scand. 2010 Sep;89(9):1233-7. doi: 10.3109/00016349.2010.498499.

PMID:
20804351
9.

Clinical experience with an integrated continuous glucose sensor/insulin pump platform: a feasibility study.

Mastrototaro JJ, Cooper KW, Soundararajan G, Sanders JB, Shah RV.

Adv Ther. 2006 Sep-Oct;23(5):725-32.

PMID:
17142207
10.
11.

Fetal growth in women managed with insulin pump therapy compared to conventional insulin.

Kernaghan D, Farrell T, Hammond P, Owen P.

Eur J Obstet Gynecol Reprod Biol. 2008 Mar;137(1):47-9.

PMID:
18006209
12.
13.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Review.

PMID:
21186142
14.

Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group., Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D.

N Engl J Med. 2008 Oct 2;359(14):1464-76. doi: 10.1056/NEJMoa0805017.

15.

Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.

Joubert M, Reznik Y.

Diabetes Res Clin Pract. 2012 Jun;96(3):294-305. doi: 10.1016/j.diabres.2011.12.010. Review.

PMID:
22209014
16.

Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy.

Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Bläsig S, Wadien T, Zierow S, Hartmann R, Thomas A.

Diabetes Technol Ther. 2011 Nov;13(11):1129-34. doi: 10.1089/dia.2011.0084.

PMID:
21827318
17.

Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy.

Lapolla A, Dalfrà MG, Masin M, Bruttomesso D, Piva I, Crepaldi C, Tortul C, Dalla Barba B, Fedele D.

Acta Diabetol. 2003 Sep;40(3):143-9.

PMID:
14605971
18.

Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study.

Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV.

Pediatr Diabetes. 2012 Feb;13(1):6-11. doi: 10.1111/j.1399-5448.2011.00793.x.

PMID:
21722284
19.

Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.

Fresa R, Visalli N, Di Blasi V, Cavallaro V, Ansaldi E, Trifoglio O, Abbruzzese S, Bongiovanni M, Agrusta M, Napoli A.

Diabetes Technol Ther. 2013 Apr;15(4):328-34. doi: 10.1089/dia.2012.0260.

PMID:
23537417
20.

Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.

O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW, Davis EA, Cameron FJ.

Diabetologia. 2009 Jul;52(7):1250-7. doi: 10.1007/s00125-009-1365-0.

PMID:
19396424
Items per page

Supplemental Content

Support Center